4-aminobenzoic acid has been researched along with Cancer of Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, R; Fu, J; Ji, H; Li, T; Ling, J; Liu, L; Yu, X; Zhang, Y | 1 |
| Böck, P; Kovacs, W; Kremser, K; Stangl, H | 1 |
| Chen, JC; Chung, JG; Lin, KM | 1 |
| Inoue, M; Ishii, H; Oda, T; Utsumi, K | 1 |
| Cao, M; Chen, J; Liu, L; Wang, J; Wang, S | 1 |
5 other study(ies) available for 4-aminobenzoic acid and Cancer of Liver
| Article | Year |
|---|---|
NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway.
Topics: 4-Aminobenzoic Acid; Animals; Antineoplastic Agents; Apoptosis; Azo Compounds; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; Mitochondria; Nitric Oxide; Oleanolic Acid; Reactive Oxygen Species; Saponins; Xenograft Model Antitumor Assays | 2012 |
Differential induction of peroxisomal enzymes by hypolipidaemics in human (HepG2) and rat (MH1C1) hepatoma cell lines.
Topics: 4-Aminobenzoic Acid; Acetyl-CoA C-Acetyltransferase; Animals; Blotting, Northern; Carcinoma, Hepatocellular; Catalase; Cell Line; Cell Survival; DNA Probes; Enzyme Induction; Humans; Hypolipidemic Agents; Liver Neoplasms; Liver Neoplasms, Experimental; Microbodies; Microscopy, Electron; para-Aminobenzoates; Rats; Succinate Dehydrogenase; Tumor Cells, Cultured | 1995 |
Effects of luteolin on arylamine N-acetyltransferase activity in human liver tumour cells.
Topics: 4-Aminobenzoic Acid; Arylamine N-Acetyltransferase; Chromatography, High Pressure Liquid; Cytosol; Dose-Response Relationship, Drug; Expectorants; Flavonoids; Fluorenes; Humans; Kinetics; Liver Neoplasms; Luteolin; Mutagens; Time Factors; Tumor Cells, Cultured | 2000 |
Cellular metabolic control by chemical modification of cell membrane.
Topics: 4-Aminobenzoic Acid; Acrolein; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Membrane; Cells, Cultured; Cobalt; Concanavalin A; Dansyl Compounds; Dicyclohexylcarbodiimide; In Vitro Techniques; Lanthanum; Liver Neoplasms; Mitochondria, Liver; Ouabain; Oxidative Phosphorylation; Oxygen Consumption; Potassium; Rats; Ruthenium Red; Trinitrobenzenesulfonic Acid | 1976 |
NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
Topics: Animals; Apoptosis; Azo Compounds; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; para-Aminobenzoates; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2019 |